VITA 34 AG (V3V.DE)
EUR 4.28
(2.88%)
EUR 4.28
(2.88%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -3.12 Million EUR | 85.33% |
| 2022 | -25.99 Million EUR | -789.9% |
| 2021 | -2.92 Million EUR | -222.73% |
| 2020 | 2.38 Million EUR | -27.48% |
| 2019 | 3.28 Million EUR | 24.74% |
| 2018 | 2.63 Million EUR | 1848.89% |
| 2017 | 135 Thousand EUR | -82.69% |
| 2016 | 780 Thousand EUR | -51.64% |
| 2015 | 1.61 Million EUR | -4.56% |
| 2014 | 1.69 Million EUR | 15.04% |
| 2013 | 1.46 Million EUR | 297.98% |
| 2012 | -742 Thousand EUR | -121.49% |
| 2011 | -335 Thousand EUR | -145.09% |
| 2010 | 743 Thousand EUR | 358.64% |
| 2009 | 162 Thousand EUR | 107.14% |
| 2008 | -2.27 Million EUR | -172.84% |
| 2007 | -832 Thousand EUR | -109.4% |
| 2006 | 8.84 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.58 Million EUR | -5.93% |
| 2024 Q1 | -1.01 Million EUR | -41.14% |
| 2023 Q3 | -89 Thousand EUR | 90.34% |
| 2023 Q4 | -717 Thousand EUR | -705.62% |
| 2023 Q1 | -1.4 Million EUR | 92.72% |
| 2023 FY | -3.81 Million EUR | 85.33% |
| 2023 Q2 | -921 Thousand EUR | 34.5% |
| 2022 Q2 | -3.67 Million EUR | -14.9% |
| 2022 FY | -25.99 Million EUR | -789.9% |
| 2022 Q3 | -313 Thousand EUR | 91.47% |
| 2022 Q4 | -19.3 Million EUR | -6068.37% |
| 2022 Q1 | -3.19 Million EUR | 29.93% |
| 2021 Q2 | 171 Thousand EUR | -45.19% |
| 2021 Q4 | -4.56 Million EUR | -553.28% |
| 2021 Q3 | 1 Million EUR | 488.3% |
| 2021 FY | -2.92 Million EUR | -222.73% |
| 2021 Q1 | 312 Thousand EUR | 310.81% |
| 2020 Q1 | 556 Thousand EUR | -4.96% |
| 2020 Q4 | -148 Thousand EUR | -112.98% |
| 2020 Q2 | 833 Thousand EUR | 49.82% |
| 2020 FY | 2.38 Million EUR | -27.48% |
| 2020 Q3 | 1.14 Million EUR | 36.85% |
| 2019 Q1 | 678 Thousand EUR | -28.56% |
| 2019 FY | 3.28 Million EUR | 24.74% |
| 2019 Q2 | 883 Thousand EUR | 30.24% |
| 2019 Q3 | 1.13 Million EUR | 28.77% |
| 2019 Q4 | 585 Thousand EUR | -48.55% |
| 2018 Q2 | 374 Thousand EUR | -30.87% |
| 2018 Q3 | 767 Thousand EUR | 105.08% |
| 2018 Q4 | 949 Thousand EUR | 23.73% |
| 2018 FY | 2.63 Million EUR | 1848.89% |
| 2018 Q1 | 541 Thousand EUR | -0.55% |
| 2017 Q3 | 450 Thousand EUR | 134.46% |
| 2017 Q1 | 445 Thousand EUR | 22350.0% |
| 2017 FY | 135 Thousand EUR | -82.69% |
| 2017 Q4 | 544 Thousand EUR | 20.89% |
| 2017 Q2 | -1.3 Million EUR | -393.48% |
| 2016 FY | 780 Thousand EUR | -51.64% |
| 2016 Q3 | 488 Thousand EUR | 92.13% |
| 2016 Q4 | -2000.00 EUR | -100.41% |
| 2016 Q2 | 254 Thousand EUR | 551.28% |
| 2016 Q1 | 39 Thousand EUR | -94.94% |
| 2015 Q4 | 771 Thousand EUR | 192.05% |
| 2015 Q3 | 264 Thousand EUR | 10.46% |
| 2015 Q1 | 339 Thousand EUR | -60.21% |
| 2015 FY | 1.61 Million EUR | -4.56% |
| 2015 Q2 | 239 Thousand EUR | -29.5% |
| 2014 Q1 | 310 Thousand EUR | -61.39% |
| 2014 Q2 | -16 Thousand EUR | -105.16% |
| 2014 Q3 | 544 Thousand EUR | 3500.0% |
| 2014 Q4 | 852 Thousand EUR | 56.62% |
| 2014 FY | 1.69 Million EUR | 15.04% |
| 2013 Q4 | 803 Thousand EUR | 124.3% |
| 2013 Q3 | 358 Thousand EUR | 42.06% |
| 2013 Q2 | 252 Thousand EUR | 350.0% |
| 2013 Q1 | 56 Thousand EUR | 129.95% |
| 2013 FY | 1.46 Million EUR | 297.98% |
| 2012 Q2 | -185 Thousand EUR | 18.14% |
| 2012 FY | -742 Thousand EUR | -121.49% |
| 2012 Q3 | -109 Thousand EUR | 41.08% |
| 2012 Q4 | -187 Thousand EUR | -71.56% |
| 2012 Q1 | -226 Thousand EUR | -437.31% |
| 2011 Q2 | -211 Thousand EUR | 38.66% |
| 2011 Q3 | 249 Thousand EUR | 218.01% |
| 2011 FY | -335 Thousand EUR | -145.09% |
| 2011 Q4 | 67 Thousand EUR | -73.09% |
| 2011 Q1 | -344 Thousand EUR | -175.44% |
| 2010 Q2 | 41 Thousand EUR | -83.67% |
| 2010 Q1 | 251 Thousand EUR | -11.62% |
| 2010 FY | 743 Thousand EUR | 358.64% |
| 2010 Q4 | 456 Thousand EUR | 124.63% |
| 2010 Q3 | 203 Thousand EUR | 395.12% |
| 2009 Q1 | -152 Thousand EUR | 0.0% |
| 2009 Q3 | 512 Thousand EUR | 3100.0% |
| 2009 FY | 162 Thousand EUR | 107.14% |
| 2009 Q4 | 284 Thousand EUR | -44.53% |
| 2009 Q2 | 16 Thousand EUR | 110.53% |
| 2008 Q2 | -784 Thousand EUR | 0.0% |
| 2008 FY | -2.27 Million EUR | -172.84% |
| 2007 FY | -832 Thousand EUR | -109.4% |
| 2006 FY | 8.84 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 1.36 Billion EUR | 100.228% |
| Fresenius SE & Co. KGaA | 1.14 Billion EUR | 100.273% |
| LIMES Schlosskliniken AG | 5.02 Million EUR | 162.079% |
| M1 Kliniken AG | 15.69 Million EUR | 119.873% |
| Maternus-Kliniken Aktiengesellschaft | -9.26 Million EUR | 66.307% |
| MEDICLIN Aktiengesellschaft | 12.72 Million EUR | 124.525% |
| RHÖN-KLINIKUM Aktiengesellschaft | 40.39 Million EUR | 107.723% |